Amedisys Welcomes Adam Holton as Chief People Officer
Amedisys Inc (AMED)
Last amedisys inc earnings: 2/18 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amedisys.com
Company Research
Source: GlobeNewswire
BATON ROUGE, La., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice, personal care and high-acuity care company, announced today that Adam Holton will join the Company as Chief People Officer. With more than 20 years of experience, Holton is an expert in leading people strategies that drive exceptional business outcomes including talent acquisition, total rewards, organizational and leadership development, employee engagement, talent management and metrics and analytics. Most recently, Holton was the Chief Human Resources Officer at Numotion, an organization dedicated to improving the lives of people with disabilities. He previously served in the same role at CHS, Inc, a F100 diversified global agribusiness cooperative that creates connections to empower agriculture. Holton has also held several HR leadership positions with General Electric, USAA and Bank One. Holton served for eight years in the United States Marine Corps as an Infan
Show less
Read more
Impact Snapshot
Event Time:
AMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMED alerts
High impacting Amedisys Inc news events
Weekly update
A roundup of the hottest topics
AMED
News
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.MarketBeat
- Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.MarketBeat
- UnitedHealth deal for Amedisys likely to close despite report of DOJ scrutiny - analyst [Seeking Alpha]Seeking Alpha
- Why Amedisys (AMED) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
AMED
Earnings
- 2/21/24 - Miss
AMED
Sec Filings
- 3/19/24 - Form 8-K
- 2/22/24 - Form 10-K
- 2/21/24 - Form 4
- AMED's page on the SEC website